Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis

作者：Hachinohe Daisuke; Jeong Myung Ho^*; Kim Min Chol; Cho Kyung Hoon; Ahmed Khurshid; Hwang Seung Hwan; Lee Min Goo; Sim Doo Sun; Park Keun Ho; Kim Ju Han; Hong Young Joon; Ahn Youngkeun; Kang Jung Chaee

来源：Korean Circulation Journal, 2011, 41(11): 677-680.

DOI：10.4070/kcj.2011.41.11.677

• Drug-eluting stents
• Coronary restenosis
• Brachytherapy
• Angioplasty

A 51-year-old man was admitted due to an acute anterior ST-segment elevation myocardial infarction. After thrombolytic therapy using recombinant tissue plasminogen activator, stent implantation was performed from the proximal left anterior descending artery (LAD) to the mid LAD using a bare-metal stent (BMS). Since then, the patient suffered five repeated episodes of in-stent restenosis (ISR). At the first ISR, he was treated with plain old balloon angioplasty (POBA). At the second ISR, he was treated with brachytherapy, and at the third ISR, he was treated with POBA and one more BMS distal to the previously implanted stent. At the forth, only POBA was performed, and finally, at the fifth ISR, a sirolimus-eluting stent was implanted. Following that, the patient remained asymptomatic and follow-up coronary angiography showed no ISR.

• 出版日期2011-11